Cargando…
Uric Acid and the Prediction Models of Tumor Lysis Syndrome in AML
We investigated the ability of serum uric acid (SUA) to predict laboratory tumor lysis syndrome (LTLS) and compared it to common laboratory variables, cytogenetic profiles, tumor markers and prediction models in acute myeloid leukemia patients. In this retrospective study patients were risk-stratifi...
Autores principales: | Ejaz, A. Ahsan, Pourafshar, Negiin, Mohandas, Rajesh, Smallwood, Bryan A., Johnson, Richard J., Hsu, Jack W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361475/ https://www.ncbi.nlm.nih.gov/pubmed/25775138 http://dx.doi.org/10.1371/journal.pone.0119497 |
Ejemplares similares
-
Controlling serum uric acid using febuxostat in cancer patients at risk of tumor lysis syndrome
por: TAKAI, MIHOKO, et al.
Publicado: (2014) -
Serum uric acid and acute kidney injury: A mini review
por: Hahn, Kai, et al.
Publicado: (2017) -
Rasburicase-Induced Falsely Low Measurement of Uric Acid in Tumor Lysis Syndrome: A Report of Two Cases
por: Yu, Lian, et al.
Publicado: (2023) -
High-risk Trans-Catheter Aortic Valve Replacement in a Failed Freestyle Valve with Low Coronary Height: A Case Report
por: Karimi, Ashkan, et al.
Publicado: (2017) -
Massive uric acid nephrolithiasis with progressive renal failure due to spontaneous tumour lysis syndrome
por: Trachsler, Johannes, et al.
Publicado: (2008)